Roncov Diagnostics And Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
About Roncov Diagnostics And Therapeutics
Roncov Diagnostics And Therapeutics Private Limited (RDATPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 August 2019 (Five years and five months 17 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Venkatesh Chelvam, Lakshmanan Vasanthi, and Latha serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85190TN2019PTC131307
-
Company No.
131307
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Aug 2019
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Roncov Diagnostics And Therapeutics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatesh Chelvam
|
Additional Director | 01-Dec-2020 | Current |
|
Lakshmanan Vasanthi
|
Director | 28-Aug-2019 | Current |
|
Latha
|
Director | 28-Aug-2019 | Current |
Financial Performance of Roncov Diagnostics And Therapeutics.
Roncov Diagnostics And Therapeutics Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Roncov Diagnostics And Therapeutics?
Unlock access to Roncov Diagnostics And Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Roncov Diagnostics And Therapeutics?
Unlock and access historical data on people associated with Roncov Diagnostics And Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Roncov Diagnostics And Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Roncov Diagnostics And Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.